Difference between revisions of "ZYUS Life Sciences, Inc."

From CannaQAWiki
Jump to navigationJump to search
(Created as needed)
 
 
Line 41: Line 41:


==History==
==History==
Formed roughly in late 2019 from what was known as CB3 Life Sciences, Inc.<ref name="ZYUSCB318">{{cite weh |url=https://www.zyus.com/news-and-events/news/news-details/2018/CB3-Life-Sciences-Ltd-Completes-Acquisition-of-World-Class-Bio-Processing-Facility/default.aspx |title=CB3 Life Sciences Ltd. Completes Acquisition of World-Class Bio-Processing Facility |publisher=ZYUS Life Sciences, Inc |date=14 February 2020}}</ref><ref name="LachardFormer19">{{cite web |url=https://mjobserver.com/people/executives/former-cannimed-ceo-launches-zyus-life-sciences-inc/ |title=Former Cannimed CEO Launches ZYUS Life Sciences Inc. |author=Lachard, S. |work=Daily Marijuana Observer |date=07 January 2019 |accessdate=14 February 2020}}</ref>, ZYUS was granted its analytical testing and research licenses in February 2020.<ref name="ZYUS20">{{cite web |url=https://www.zyus.com/news-and-events/news/news-details/2020/ZYUS-Life-Sciences-Receives-Analytical-Testing-and-Research-Licences-from-Health-Canada-Further-Enabling-Medical-Cannabis-Product-Development-and-Production/default.aspx |title=ZYUS Life Sciences Receives Analytical Testing and Research Licences from Health Canada Further Enabling Medical Cannabis Product Development and Production |publisher=ZYUS Life Sciences, Inc |date=14 February 2020}}</ref>
Formed roughly in late 2019 from what was known as CB3 Life Sciences, Inc.<ref name="ZYUSCB318">{{cite web |url=https://www.zyus.com/news-and-events/news/news-details/2018/CB3-Life-Sciences-Ltd-Completes-Acquisition-of-World-Class-Bio-Processing-Facility/default.aspx |title=CB3 Life Sciences Ltd. Completes Acquisition of World-Class Bio-Processing Facility |publisher=ZYUS Life Sciences, Inc |date=14 February 2020}}</ref><ref name="LachardFormer19">{{cite web |url=https://mjobserver.com/people/executives/former-cannimed-ceo-launches-zyus-life-sciences-inc/ |title=Former Cannimed CEO Launches ZYUS Life Sciences Inc. |author=Lachard, S. |work=Daily Marijuana Observer |date=07 January 2019 |accessdate=14 February 2020}}</ref>, ZYUS was granted its analytical testing and research licenses in February 2020.<ref name="ZYUS20">{{cite web |url=https://www.zyus.com/news-and-events/news/news-details/2020/ZYUS-Life-Sciences-Receives-Analytical-Testing-and-Research-Licences-from-Health-Canada-Further-Enabling-Medical-Cannabis-Product-Development-and-Production/default.aspx |title=ZYUS Life Sciences Receives Analytical Testing and Research Licences from Health Canada Further Enabling Medical Cannabis Product Development and Production |publisher=ZYUS Life Sciences, Inc |date=14 February 2020}}</ref>


==Locations==
==Locations==

Latest revision as of 22:10, 14 February 2020

ZYUS Life Sciences, Inc.
Type Incorporated (inc.)
Industry Manufacturing, R&D
Headquarters 204 - 407 Downey Rd., Saskatoon, Saskatchewan, Canada
Number of locations 1
Area served Canada
Key people Brent Zettl
Services Manufacturing, R&D, Cannabis testing
Website zyus.com
LinkedIn https://www.linkedin.com/company/zyuslifesciences/

ZYUS Life Sciences, Inc. develops and manufactures Cannabis-based products. As part of its production and research, ZYUS has an R&D and chemical Cannabis testing laboratory licensed by the Canadian government.[1]

History

Formed roughly in late 2019 from what was known as CB3 Life Sciences, Inc.[2][3], ZYUS was granted its analytical testing and research licenses in February 2020.[4]

Locations

The following laboratory locations are known. Services may vary among locations:

Pricing

Test pricing is irrelevant to this business.

Additional information

References